NCT06498037View on ClinicalTrials.gov

Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn.

PHASE4RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 23, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

December 2, 2025

Conditions
Cancer Pain
Interventions
DRUG

Fentanyl

Administration of subcutaneously administered fentanyl loading boluses

Trial Locations (1)

3015 GD

RECRUITING

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER